| Proteobacteria: a common factor in human diseases G Rizzatti, LR Lopetuso, G Gibiino, C Binda, A Gasbarrini BioMed research international 2017 (1), 9351507, 2017 | 916 | 2017 |
| Commensal Clostridia: leading players in the maintenance of gut homeostasis LR Lopetuso, F Scaldaferri, V Petito, A Gasbarrini Gut pathogens 5, 1-8, 2013 | 848 | 2013 |
| Food components and dietary habits: keys for a healthy gut microbiota composition E Rinninella, M Cintoni, P Raoul, LR Lopetuso, F Scaldaferri, G Pulcini, ... Nutrients 11 (10), 2393, 2019 | 582 | 2019 |
| Actinobacteria: a relevant minority for the maintenance of gut homeostasis C Binda, LR Lopetuso, G Rizzatti, G Gibiino, V Cennamo, A Gasbarrini Digestive and Liver Disease 50 (5), 421-428, 2018 | 553 | 2018 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 389 | 2019 |
| Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ... BioMed research international 2013 (1), 435268, 2013 | 299 | 2013 |
| The gut barrier: new acquisitions and therapeutic approaches F Scaldaferri, M Pizzoferrato, V Gerardi, L Lopetuso, A Gasbarrini Journal of clinical gastroenterology 46, S12-S17, 2012 | 267 | 2012 |
| European Crohn’s and Colitis Organisation topical review on treatment withdrawal [‘exit strategies’] in inflammatory bowel disease G Doherty, KH Katsanos, J Burisch, M Allez, K Papamichael, A Stallmach, ... Journal of Crohn's and Colitis 12 (1), 17-31, 2018 | 195 | 2018 |
| Nutrition and IBD: malnutrition and/or sarcopenia? A practical guide F Scaldaferri, M Pizzoferrato, LR Lopetuso, T Musca, F Ingravalle, ... Gastroenterology research and practice 2017 (1), 8646495, 2017 | 192 | 2017 |
| Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update F Scaldaferri, V Gerardi, F Mangiola, LR Lopetuso, M Pizzoferrato, ... World journal of gastroenterology 22 (24), 5505, 2016 | 192 | 2016 |
| Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals G Gibiino, LR Lopetuso, F Scaldaferri, G Rizzatti, C Binda, A Gasbarrini Digestive and Liver Disease 50 (7), 635-639, 2018 | 184 | 2018 |
| Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders. IG Macchione, LR Lopetuso, G Ianiro, M Napoli, G Gibiino, G Rizzatti, ... European Review for Medical & Pharmacological Sciences 23 (18), 2019 | 178 | 2019 |
| Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders LR Lopetuso, V Petito, C Graziani, E Schiavoni, F Paroni Sterbini, ... Digestive diseases 36 (1), 56-65, 2017 | 174 | 2017 |
| Opposing functions of classic and novel IL-1 family members in gut health and disease LR Lopetuso, S Chowdhry, TT Pizarro Frontiers in immunology 4, 181, 2013 | 169 | 2013 |
| Role of Helicobacter pylori infection on nutrition and metabolism F Franceschi, T Annalisa, G Ianiro, S Franco, G Viviana, T Valentina, ... World journal of gastroenterology: WJG 20 (36), 12809, 2014 | 161 | 2014 |
| Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection … G Ianiro, L Masucci, G Quaranta, C Simonelli, LR Lopetuso, M Sanguinetti, ... Alimentary pharmacology & therapeutics 48 (2), 152-159, 2018 | 153 | 2018 |
| The role of antibiotics in gut microbiota modulation: the eubiotic effects of rifaximin FR Ponziani, F Scaldaferri, V Petito, F Paroni Sterbini, S Pecere, ... Digestive Diseases 34 (3), 269-278, 2016 | 153 | 2016 |
| The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors LR Lopetuso, F Scaldaferri, G Bruno, V Petito, F Franceschi, A Gasbarrini European review for medical and pharmacological sciences 9 (6), 1068-1076, 2015 | 147 | 2015 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 122 | 2020 |
| Gut microbiota profiling and gut–brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders … A Quagliariello, F Del Chierico, A Russo, S Reddel, G Conte, ... Frontiers in microbiology 9, 675, 2018 | 118 | 2018 |
